Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria

Experimental Hematology

Volumn 36, Issue 4, 2008, Pages 369-377

  Amer, Johnny ^a   Zelig, Orly ^a   Fibach, Eitan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; CD59 ANTIGEN; COMPLEMENT; DECAY ACCELERATING FACTOR; GLUTATHIONE; HYDROGEN PEROXIDE; LIPID PEROXIDE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NEUTROPHIL; OXIDATIVE STRESS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; THROMBOCYTE;

ACETYLCYSTEINE; ANEMIA; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; BLOOD PLATELETS; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; HYDROGEN PEROXIDE; MALE; NEUTROPHILS; OXIDANTS; OXIDATIVE STRESS; REFERENCE VALUES; THROMBOSIS; TOCOPHEROLS;

EID: 40649086619     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.12.003     Document Type: Article

References (38)

1. Takeda J., Miyata T., Kawagoe K., et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73 (1993) 703-711
2. Inoue N., Murakami Y., and Kinoshita T. Molecular genetics of paroxysmal nocturnal hemoglobinuria. Int J Hematol 77 (2003) 107-112
3. Parker C.J. The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol 35 (2007) 523-533
4. Meletis J., and Terpos E. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria. Med Sci Monit 9 (2003) RA161-RA172
5. Smith L.J. Paroxysmal nocturnal hemoglobinuria. Clin Lab Sci 17 (2004) 172-177
6. Rosse W.F. New insights into paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol 8 (2001) 61-67
7. Hall C., Richards S.J., and Hillmen P. The glycosylphosphatidylinositol anchor and paroxysmal nocturnal haemoglobinuria/aplasia model. Acta Haematol 108 (2002) 219-230
8. Holguin M.H., Fredrick L.R., Bernshaw N.J., Wilcox L.A., and Parker C.J. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84 (1989) 7-17
9. Marsh J.C., and Elebute M.O. Stem cells in paroxysmal nocturnal haemoglobinuria and aplastic anaemia: increasing evidence for overlap of haemopoietic defect. Transfus Med 13 (2003) 377-386
10. Walport M.J. Complement. First of two parts. N Engl J Med 344 (2001) 1058-1066
11. Rosse W.F. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 75 (1990) 1595-1601
12. Amer J., Goldfarb A., and Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 70 (2003) 84-90
13. Amer J., and Fibach E. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost 92 (2004) 1052-1059
14. Amer J., Goldfarb A., and Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 60 (2004) 73-80
15. Amer J., and Fibach E. Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients. Br J Haematol 129 (2005) 435-441
16. Amer J., Etzion Z., Bookchin R.M., and Fibach E. Oxidative status of valinomycin-resistant normal, beta-thalassemia and sickle red blood cells. Biochim Biophys Acta 1760 (2006) 793-799
17. Amer J., Ghoti H., Rachmilewitz E., Koren A., Levin C., and Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 132 (2006) 108-113
18. Gonzalez Moraleja J., Rubio Perez P., Cabello Carro J., Garcia-Casasola G., and Alvarez-Sala J.L. [Recurrent infections, severe neutropenia and neutrophil chemotaxis defect in paroxysmal nocturnal hemoglobinuria]. Ann Med Intern 11 (1994) 490-492
19. Gralnick H.R., Vail M., McKeown L.P., et al. Activated platelets in paroxysmal nocturnal haemoglobinuria. Br J Haematol 91 (1995) 697-702
20. Fujioka S., and Yamada T. Varying populations of CD59-negative, partly positive, and normally positive blood cells in different cell lineages in peripheral blood of paroxysmal nocturnal hemoglobinuria patients. Am J Hematol 45 (1994) 122-127
21. Young N.S. Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment. Curr Hematol Rep 4 (2005) 103-109
22. Filosa A., Valgimigli L., Pedulli G.F., et al. Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy. Br J Haematol 131 (2005) 135-140
23. Walter P.B., Fung E.B., Killilea D.W., et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 135 (2006) 254-263
24. Bird R.P., and Draper H.H. Comparative studies on different methods of malonaldehyde determination. Methods Enzymol 105 (1984) 299-305
25. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
26. Kohen R., and Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30 (2002) 620-650
27. Mengel C.E., Ebbert L., Stickney D., Essig L., and Brubaker L. Biochemistry of PNH cells: nature of the membrane defect. Ser Haematol 5 (1972) 88-100
28. Shingu M., Nonaka S., Nishimukai H., Nobunaga M., Kitamura H., and Tomo-Oka K. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exp Immunol 90 (1992) 72-78
29. Socie G., Mary J.Y., de Gramont A., et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 348 (1996) 573-577
30. Wiedmer T., Hall S.E., Ortel T.L., Kane W.H., Rosse W.F., and Sims P.J. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82 (1993) 1192-1196
31. Eldor A., and Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood 99 (2002) 36-43
32. Eidt J.F., Allison P., Noble S., et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 84 (1989) 18-27
33. Hanson S.R., and Harker L.A. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci U S A 85 (1988) 3184-3188
34. Iuliano L., Violi F., Pedersen J.Z., Pratico D., Rotilio G., and Balsano F. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch Biochem Biophys 299 (1992) 220-224
35. Blockmans D., Deckmyn H., and Vermylen J. Platelet activation. Blood Rev 9 (1995) 143-156
36. Ninomiya H., Kawashima Y., Hasegawa Y., and Nagasawa T. Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH. Br J Haematol 106 (1999) 224-231
37. Thomas T.C., and Rollins S.A. Rother et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol 33 (1996) 1389-1401
38. Hillmen P., Hall C., Marsh J.C., et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350 (2004) 552-559